Outpatient Therapeutics
- January 31, 2023
-
Outpatient Therapeutics
DOH Issues Revised Guidance on COVID-19 Treatment Recommendations Members encouraged to share information with their medical directors and physicians.
- Read More
- January 26, 2023
-
Outpatient Therapeutics
DOH Advisory: Updates on COVID-19 Treatment Recommendations - Read More
- November 30, 2022
-
Outpatient Therapeutics
DOH Advisory: Updates on COVID-19 Treatment Recommendations - Read More
- May 31, 2022
-
Outpatient Therapeutics
DOH Issues Health Advisory Regarding Paxlovid Use Advisory relates to use of Paxlovid and potential for rebound COVID-19 after treatment.
- Read More
- May 24, 2022
-
Outpatient Therapeutics
DOH Advisory: COVID-19 Rebound After Paxlovid Treatment - Read More
- April 25, 2022
-
Outpatient Therapeutics
Access to COVID-19 Therapeutics: Reminders for Nursing Homes Nursing homes that operate their own pharmacy must enroll in a specialized system to request monoclonal antibody therapies and may request oral antivirals by sending a request to covid19therapeutics@health.ny.gov or through the Health Partner Order Portal. Nursing homes that do not operate their own pharmacy may access therapeutics through their LTC pharmacy.
- Read More
- April 19, 2022
-
Outpatient Therapeutics
DOH Advisory: COVID-19 Oral Antiviral Treatment Available - Read More
- March 29, 2022
-
Outpatient Therapeutics
DOH Issues Advisory on Pause in Distribution of Sotrovimab Currently authorized alternative treatments, including Paxlovid, molnupiravir, and bebtelovimab, available for distribution.
- Read More
- March 25, 2022
-
Outpatient Therapeutics
DOH Advisory: Pause in Distribution of Sotrovimab - Read More
- March 4, 2022
-
Outpatient Therapeutics
DOH Advisory: Test Soon and Treat Early to Improve Outcomes from COVID-19 - Read More
-
- view more